Toxicity of cuprizone a Cu²⁺ chelating agent on isolated mouse brain mitochondria: a justification for demyelination and subsequent behavioral dysfunction

References

• Acs P, Komoly S. (2012). Selective ultrastructural vulnerability in the cuprizone-induced experimental demyelination. Ideggy Szemle 65:266–70.
   PubMedGoogle Scholar
• Babincova M, Machova E, Kogan G. (1999). Carboxymethylated glucan inhibits lipid peroxidation in liposomes. Z Naturforsch C J Biosci 54:1084–8.
   PubMed Web of Science ®Google Scholar
• Babincova M, Bacova Z, Machova E, Kogan G. (2002). Antioxidant properties of carboxymethyl glucan: comparative analysis. J Med Food 5:79–83.
   PubMedGoogle Scholar
• Bader PL, Faizi M, Kim LH, et al. (2011). Mouse model of Timothy syndrome recapitulates triad of autistic traits. Proc Natl Acad Sci U S A 108:15432–7.
   PubMed Web of Science ®Google Scholar
• Beal MF. (1995). Aging, energy, and oxidative stress in neurodegenerative diseases. Ann Neurol 38:357–66.
   PubMed Web of Science ®Google Scholar
• Bénardais K, Kotsiari A, Škuljec J, et al. (2013). Cuprizone [bis (cyclohexylidenehydrazide)] is selectively toxic for mature oligodendrocytes. Neurotox Res 24:244–50.
   PubMed Web of Science ®Google Scholar
• Blakemore W. (1973). Demyelination of the superior cerebellar peduncle in the mouse induced by cuprizone. J Neurol Sci 20:63–72.
   PubMed Web of Science ®Google Scholar
• Bradford MM. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–54.
   PubMed Web of Science ®Google Scholar
• Bradley WG. (2004). Neurology in clinical practice: principles of diagnosis and management (Chapter 20: Disturbances of taste and smell). New York: Taylor & Francis.
   Google Scholar
• Drury R. (1981). Theory and practice of histotechnology. J Clin Pathol 34:1406.
   Google Scholar
• Du G, Mouithys-Mickalad A, Sluse FE. (1998). Generation of superoxide anion by mitochondria and impairment of their functions during anoxia and reoxygenation in vitro. Free Radic Biol Med 25:1066–74.
   PubMed Web of Science ®Google Scholar
• Eliaeson K, Liljeberg M, Bjork A, et al. (2008). Relationships of geochemistry and multiple sclerosis. Gothenburg, SE: Swedish Enviromental Research Institute.
   Google Scholar
• Ferguson B, Matyszak MK, Esiri MM, Perry VH. (1997). Axonal damage in acute multiple sclerosis lesions. Brain 120:393–9.
   PubMed Web of Science ®Google Scholar
• Goldberg J, Daniel M, van Heuvel Y, et al. (2013). Short-term cuprizone feeding induces selective amino acid deprivation with concomitant activation of an integrated stress response in oligodendrocytes. Cell Mol Neurobiol 33:1087–98.
   PubMed Web of Science ®Google Scholar
• Guerineau M, Guerineau S, Gosse C. (1974). Abnormal Mitochondrial DNA Molecules in Megamitochondria from cuprizone-treated rats. Eur J Biochem 47:313–9.
   PubMedGoogle Scholar
• Jarskog LF, Glantz LA, Gilmore JH, Lieberman JA. (2005). Apoptotic mechanisms in the pathophysiology of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 29:846–58.
   PubMed Web of Science ®Google Scholar
• Kehrberg AMH. (2006). Neuronal nitric oxide protects the developing cerebellum against alcohol-induced functional and cellular deficits. ProQuest. University of Iowa, USA.
   Google Scholar
• Kowaltowski AJ, Castilho RF, Vercesi AE. (2001). Mitochondrial permeability transition and oxidative stress. FEBS Letters 495:12–5.
   PubMed Web of Science ®Google Scholar
• Lambowitz AM. (1979). Preparation and analysis of mitochondrial ribosomes. Methods Enzymol 59:421–33.
   PubMedGoogle Scholar
• Lu F, Selak M, O’Connor J, et al. (2000). Oxidative damage to mitochondrial DNA and activity of mitochondrial enzymes in chronic active lesions of multiple sclerosis. J Neurol Sci 177:95–103.
   PubMed Web of Science ®Google Scholar
• Ludwin S. (1978). Central nervous system demyelination and remyelination in the mouse: an ultrastructural study of cuprizone toxicity. Lab Invest 39:597–612.
   PubMed Web of Science ®Google Scholar
• Luszczki JJ, Andres MM, Czuczwar P, et al. (2005). Levetiracetam selectively potentiates the acute neurotoxic effects of topiramate and carbamazepine in the rotarod test in mice. Eur Neuropsychopharmacol 15:609–16.
   PubMed Web of Science ®Google Scholar
• Mahad D, Ziabreva I, Lassmann H, Turnbull D. (2008). Mitochondrial defects in acute multiple sclerosis lesions. Brain 131:1722–35.
   PubMed Web of Science ®Google Scholar
• Moser VC. (1989). Screening approaches to neurotoxicity: a functional observational battery. Int J Toxicol 8:85–93.
   Web of Science ®Google Scholar
• Pirahmadi N, Fazeli M, Zarghi A, et al. (2015). 4-(4-(Methylsulfonyl) phenyl)-3-phenoxy-1-phenylazetidin-2-one: a novel COX-2 inhibitor acting selectively and directly on cancerous B-lymphocyte mitochondria. Toxicol Environ Chem 97:908–21.
   Web of Science ®Google Scholar
• Praet J, Guglielmetti C, Berneman Z, et al. (2014). Cellular and molecular neuropathology of the cuprizone mouse model: clinical relevance for multiple sclerosis. Neurosci Biobehav Rev 47:485–505.
   PubMed Web of Science ®Google Scholar
• Prodan C, Holland N, Wisdom P, et al. (2002). CNS demyelination associated with copper deficiency and hyperzincemia. Neurology 59:1453–6.
   PubMed Web of Science ®Google Scholar
• Rossi L, Lombardo MF, Ciriolo MR, Rotilio G. (2004). Mitochondrial dysfunction in neurodegenerative diseases associated with copper imbalance. Neurochem Res 29:493–504.
   PubMed Web of Science ®Google Scholar
• Shaki F, Hosseini M-J, Ghazi-Khansari M, Pourahmad J. (2013). Depleted uranium induces disruption of energy homeostasis and oxidative stress in isolated rat brain mitochondria. Metallomics 5:736–44.
   PubMed Web of Science ®Google Scholar
• Tiwari BS, Belenghi B, Levine A. (2002). Oxidative stress increased respiration and generation of reactive oxygen species, resulting in ATP depletion, opening of mitochondrial permeability transition, and programmed cell death. Plant Physiol 128:1271–81.
   PubMed Web of Science ®Google Scholar
• Wakabayashi T, Asano M, Kurono C. (1975). Mechanism of the formation of megamitochondria induced by copper‐chelating agents. Pathol Int 25:15–37.
   Google Scholar
• Wakabayashi T. (2002). Megamitochondria formation – physiology and pathology. J Cell Mol Med 6:497–538.
   PubMed Web of Science ®Google Scholar
• Wallace DC. (1992). Diseases of the mitochondrial DNA. Annu Rev Biochem 61:1175–212.
   PubMed Web of Science ®Google Scholar
• Witte ME, Mahad DJ, Lassmann H, van Horssen J. (2014). Mitochondrial dysfunction contributes to neurodegeneration in multiple sclerosis. Trends Mol Med 20:179–87.
   PubMed Web of Science ®Google Scholar
• Xu W, Barrientos T, Andrews NC. (2013). Iron and copper in mitochondrial diseases. Cell Metab 17:319–28.
   PubMed Web of Science ®Google Scholar
• Yoshikawa S, Muramoto K, Shinzawa-Itoh K. (2011). Proton-pumping mechanism of cytochrome c oxidase. Annu Rev Biophys 40:205–23.
   PubMed Web of Science ®Google Scholar